___

[1]Tozkoparan, B.,Aytaç, S.P., 2007. Kanser kemoterapisinde terapötik hedef olarak glutatyon s-transferazlar. Hacettepe Üniversitesi, Eczacılık Fakültesi Dergisi, 27(2), 139-64.

[2]Domaç, M. (Ed.) 2005. Kemoterapötikler.Fersa Matbaacılık Ltd., Ankara,96s.

[3]Kayaalp, O.2000. Rasyonel Tedavi Yönünden Tıbbi Farmakoloji. Hacettepe-Taş Kitapçılık Ltd. Şti, Ankara, 880s.

[4]Süzer, Ö. (Ed.)2009. Goodman & GillmanTedavinin Farmakolojik Temeli. Nobel Tıp Kitabevi, Ankara, 2017s.

[5]Kazakevich, Y., Lobrutto, Y.2007. HPLC for Pharmaceutical Scientists. Wiley-Interscience,Canada, USA, 1135s.

[6]ICH Expert Working Group, 2005, April. Validation of analytical procedures: text and methodology Q2 (R1). In Proceedings of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva, Switzerland.

[7]Meyer, V.R.2010. Practical High-Performance Liquid Chromatography. John Wiley and Sons, Ltd., United Kingdom, 428s.

[8]Uysal, R., Daldal, Y.D., Üstün, Z., Çubuk Demiralay, E.2017. Optimization of RPLC Method for Separation of Some Acetylcholinesterase Inhibitors by using Central Composite Design. Eurasian Journal of Analytical Chemistry, 12(1), 23-43.

[9]Gündoğan, B., Çubuk Demiralay, E., Daldal, Y.D., Üstün, Z.2017. Determination of Optimum Separation Condition for Some Carbapenem Antibiotics Using RPLC with the Aid of Central Composite Design and Desirability Function. Current Pharmaceutical Analysis, 13,100-109.

[10]Çubuk Demiralay, E.2012. An Experimental Design Ap proach to Optimization of the Liquid Chromatographic Separation Conditions for the Determination of Metformin and Glibenclamide in Pharmaceutical Formulation. Acta ChimaSlovenica, 59(2), 307-314.

[11]Myers, R.H., Montgomery, D.C.2002. Response Surface Methodology.Wiley, New York, 798s.

[12]Montgomery, D.C.2005. Design and Analysis of Experiments. John Wiley &Sons, Westford, 757s.

[13]Meloun, M., Zuzana Ferenčiková, Vrána, A.2011. Determination of The Thermodynamic Dissociation Constant of Capecitabine Using Spectrophotometric and Potentiometric Titration Data.The Journal of Chemical Thermodynamics, 43, 930–937.

[14]Ɫaszcz,M., Trzcińska, K., Filip, K., Szyprowska, A., Mucha,M.,Krzeczyński, P. 2011. Stability Studies of Capecitabine. Journal of Thermal Analysis and Calorimetry, 105, 1015-1021.

[15]Pujeri, S.S.,Khader, A. M. A., Seetharamappa, J.2012. Stability Study of CapecitabineActive Pharmaceutical Ingredientin Bulk Drug and PharmaceuticalFormulation. Journal of Liquid Chromatography & Related Technologies, 35, 40-49.

[16]Wang, X.J, You, J.Z.2016. Study on The Thermal Decomposition of Capecitabine. Journal of Thermal Analysis and Calorimetry, 123, 2485-2497.

[17]Farkouh, A., Ettlinger, D., Schueller, J., Georgopoulos, A.,Scheithauer, W., Czejka, M. 2010. A Rapid and Simple HPLC Assay for Quantification ofCapecitabine for Drug Monitoring Purposes. Anticancer Research,30, 5207-5212.

[18]Deenen, M.J., Rosing, H., Hillebrand, M.J., Schellens, J.H.M., Beijnen, J. H.2013. Quantitative Determination of Capecitabine and İts Six Metabolites in HumanPlasma Using Liquid Chromatography Coupled to Electrospray Tandem MassSpectrometry. Journal of Chromatography B, 913, 30–40.

[19]Deng, P., Ji, C., Daia, X., Zhong, D., Ding, L., Chen, X. 2015. Simultaneous Determination of Capecitabine and its Three Nucleosidemetabolites in Human Plasma by High Performance Liquid Chromatography-Tandem Mass Spectrometry. Journal of Chromatography B, 989, 71–79.

[20]Jacobs, B. A.W., Rosing, H., de Vries, N., Meulendijks, D., Henricks, L. M., Schellens, J.H.M., Beijnen, J.H.2016. Development and Validation Of A Rapid and Sensitive UPLC–MS/MSMethod for Determination of Uracil and Dihydrouracil in HumanPlasma. Journal of Pharmaceutical and Biomedical Analysis,126,75-82.

[21]Stashkevich, M.A., Khomutov, E.V., Dumanskii, Y.V.,Matvienko, A.G., Zinkovich, I.I. 2016. Effect of 5-Fluorouracil on Thymidine Phosphorylasectivity in Model Experiment. Bulletin of Experimental Biology and Medicine, 160(5),646-647.

[22]Daldal, Y.D. 2018. Kemoterapide kullanılan bazı antimetabolit ilaçların sıvı kromatografik tayininde merkezi kompozit dizayn tekniğinin uygulanması. Süleyman Demirel Üniversitesi, Fen Bilimleri Enstitüsü,DoktoraTezi, 233s, Isparta.

[23]Daldal, Y.D.,Demiralay, E.Ç., Ozkan, S.A. 2016. Effect of Organic Solvent Composition on Dissociation Constants of Some Reversible Acetylcholinesterase Inhibitors, Journal of the Brazilian Chemical Society, 27(3), 493-499.